跳至主要内容
临床试验/NL-OMON25764
NL-OMON25764尚未招募不适用

Atosiban versus placebo in the treatment of threatened preterm birth: a randomised double blind trial.

Academic Medical CenterP.O. box 226601100 DD AmsterdamTel. 020 - 566 91110 个研究点目标入组 1,514 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,514

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Woman = 18 years old
  • - Singleton or twin pregnancy
  • - Gestational age between 30 0/7 and 33 6/7 weeks
  • - Threatened preterm birth defined by regular uterine contractions and one of the following:
  • - Cervical length of < 15 mm or
  • - Cervical length of 15-30 mm and a positive fFn test (= 50 ng/mL) or in case of absence of cervical length
  • measurement in local protocol a positive Fibronectin test or Partus test
  • - Ruptured amniotic membranes

排除标准

  • - Previous treatment for threatened preterm birth with corticosteroids in current pregnancy
  • - Contra indication for tocolysis
  • - Signs of fetal distress
  • - Signs of intra uterine infection
  • - Fetal chromosomal or severe congenital abnormalities

研究者

发起方
Academic Medical CenterP.O. box 226601100 DD AmsterdamTel. 020 - 566 9111

相似试验